These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7565857)

  • 1. Pharmacokinetic considerations in phenytoin pharmacotherapy: preventing overdoses and underdoses.
    Profeta LM; Bradbury K; Mehl B
    Mt Sinai J Med; 1995 Sep; 62(4):312-4. PubMed ID: 7565857
    [No Abstract]   [Full Text] [Related]  

  • 2. [Subtherapeutic blood levels of phenytoin due to a medication error].
    Burri E; Rüegg S; Rutishauser J; Egger SS; Lampert ML
    Praxis (Bern 1994); 2007 Apr; 96(17):687-92. PubMed ID: 17491199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal obstruction and phenytoin intoxication.
    Miura T; Kasai H
    Pediatr Int; 2009 Jun; 51(3):431-2. PubMed ID: 19500289
    [No Abstract]   [Full Text] [Related]  

  • 4. Altered phenytoin pharmacokinetics in children with severe, acute traumatic brain injury.
    Stowe CD; Lee KR; Storgion SA; Phelps SJ
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1452-61. PubMed ID: 11185666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phenytoin].
    Furuno K; Kawasaki H; Gomita Y
    Nihon Rinsho; 1995 Feb; 53 Su Pt 1():924-7. PubMed ID: 8753589
    [No Abstract]   [Full Text] [Related]  

  • 6. Problems with phenytoin administration in neurology/neurosurgery ITU patients receiving enteral feeding.
    Kitchen D; Smith D
    Seizure; 2001 Jun; 10(4):265-8. PubMed ID: 11466022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of honey on the pharmacokinetics of phenytoin in healthy rabbits.
    Sukriti ; Garg SK
    Methods Find Exp Clin Pharmacol; 2003 Jun; 25(5):367-70. PubMed ID: 12851659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of pharmacokinetic interaction between zileuton and phenytoin in humans.
    Samara E; Cavanaugh JH; Mukherjee D; Granneman GR
    Clin Pharmacokinet; 1995; 29 Suppl 2():84-91. PubMed ID: 8620675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of Four Protein-Binding Models Characterizing the Pharmacokinetics of Unbound Phenytoin in Adult Patients Using Non-Linear Mixed-Effects Modeling.
    Jun H; Rong Y; Yih C; Ho J; Cheng W; Kiang TKL
    Drugs R D; 2020 Dec; 20(4):343-358. PubMed ID: 33026608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of plasma free phenytoin measurement and factors influencing its protein binding.
    Iwamoto T; Kagawa Y; Naito Y; Kuzuhara S; Okuda M
    Biopharm Drug Dispos; 2006 Mar; 27(2):77-84. PubMed ID: 16308884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum albumin-adjusted phenytoin levels: an approach for predicting drug efficacy in patients with epilepsy, suitable for developing countries.
    Tandon M; Pandhi P; Garg SK; Prabhakar SK
    Int J Clin Pharmacol Ther; 2004 Oct; 42(10):550-5. PubMed ID: 15516024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring of phenytoin in critically ill patients.
    von Winckelmann SL; Spriet I; Willems L
    Pharmacotherapy; 2008 Nov; 28(11):1391-400. PubMed ID: 18956999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing phenytoin intoxication: safer use of a familiar anticonvulsant.
    Glick TH; Workman TP; Gaufberg SV
    J Fam Pract; 2004 Mar; 53(3):197-202. PubMed ID: 15000924
    [No Abstract]   [Full Text] [Related]  

  • 14. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Burkhardt RT; Leppik IE; Blesi K; Scott S; Gapany SR; Cloyd JC
    Neurology; 2004 Oct; 63(8):1494-6. PubMed ID: 15505173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the phenytoin-enteral feeding formula interaction a myth?
    Bertino JS
    Nutr Clin Pract; 1996 Aug; 11(4):175-6. PubMed ID: 9070019
    [No Abstract]   [Full Text] [Related]  

  • 16. Fosphenytoin facts.
    Chioffi SM; Lassiter TF; Scates AC; McLendon BM
    Am J Nurs; 1999 Aug; 99(8):14. PubMed ID: 10456012
    [No Abstract]   [Full Text] [Related]  

  • 17. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Sherry JH; Bechtel T
    Neurology; 2005 Aug; 65(4):657-8; author reply 657-8. PubMed ID: 16118859
    [No Abstract]   [Full Text] [Related]  

  • 18. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Rackley RJ
    Neurology; 2005 Aug; 65(4):657-8; author reply 657-8. PubMed ID: 16118860
    [No Abstract]   [Full Text] [Related]  

  • 19. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Perron R
    Neurology; 2005 Apr; 64(8):1485-6; author reply 1485-6; discussion 1485-6. PubMed ID: 15858865
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenytoin suppositories and echinacea.
    Kaatz B
    S D J Med; 1997 Sep; 50(9):335. PubMed ID: 9314727
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.